Vein Vascular Prosthesis

A “fistula first” approach has been the standard for hemodialysis patients for a long time. However, fistulas can fail in 20 to 60 percent of cases,1-5 resulting in patients experiencing undue hardship and risks associated with central venous catheters (CVCs).input:
output:This is one of the reasons the 2019 Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines6 underscore the necessity of a more personalized approach to access modality selection.input:
output:It pertains to the “appropriate access, in the appropriate patient, at the appropriate time, for the appropriate reasons.”input:
output:- KDOQI guidelinesinput:
output:The GORE® ACUSEAL Vascular Graft is the optimal choice for patients who are at risk of fistula non-maturation, as it is designed to provide long-term and rapid access for the future. It is the optimal choice for patients who require a new access and require cannulation within two weeks, or those who are already on a CVC.input:
output:It facilitates the earlier removal or avoidance of a CVC and assists in the successful completion of hemodialysis by reducing the number of access-related procedures and complications, thereby allowing for greater confidence at every stage.input:
output:REDUCED TOTAL COST OF CARE:By enabling the earlier removal of CVCs, the cost of treating CVC sepsis is reduced.*, teninput:
output:Developed with the consideration of your patients

Due to the fact that dialysis is a personal matterinput:
output:The GORE® ACUSEAL Vascular Graft’s tri-layer design is designed to facilitate early cannulation and ensure uncompromised handling.input:
output:Designed with an elastomeric middle layer that functions as a low-bleed barrier to cannulation needle holes, this device is specifically engineered for immediate cannulation.

Flexible in the presence of curves without kinking.

The GORE® ACUSEAL Vascular Graft is also equipped with CBAS® Heparin Surface technology, which is a primary cause of AVG failure, in order to prevent thrombosis.eleven